27 research outputs found
BioEnterics Intragastric Balloon: Clinical outcomes of the first 100 patients - A Turkish experience
Background The BioEnterics Intragrastric Balloon (BIB (R)) together with restricted diet has been used for the treatment of obesity and morbid obesity
Is Timing Important in Thyroid Reoperation?
Objective: Although it is recommended to perform completion thyroidectomy as soon as possible after the initial operation, there are no consensus guidelines about the appropriate time interval for the reoperation. The aim of the present study was to compare the postoperative complications, the amount of residual tissue, and postoperative thyroid-stimulating hormone (TSH) and thyroglobulin (Tg) levels following completion thyroidectomy that was performed at different time intervals
The change in the principle of performing laparoscopic adrenalectomy from small to large masses
Background: Laparoscopic adrenalectomy has become the gold standard in most patients with adrenal tumors. It is unclear; however, at what size an adrenal neoplasm should be resected by means of an open or a laparoscopic approach. The aim of the present study was to compare the outcomes of laparoscopic adrenalectomy for large tumors with smaller tumors
Role of vascular endothelial growth factor in the prognosis of papillary thyroid cancer
Vascular endothelial growth factor (VEGF) induces proliferation of endothelial cells, stimulates angiogenesis, and increases vascular permeability. Increased VEGF expression has been associated with poor clinical outcomes in many malignancies. Several recent reports have documented overexpression of VEGF in papillary thyroid cancer. We studied the relationship between increased expression of VEGF and an increased risk of recurrence. The aims of this study were to determine whether immunohistochemical expression of VEGF is related to local and distant recurrence of papillary thyroid cancer and to evaluate the relationship between hypervascularization and VEGF expression in papillary thyroid carcinoma. VEGF expression was examined immunohistochemically in 45 papillary carcinomas. Ten patients with normal thyroid glands who underwent surgery between 1991 and 1992 were used as controls. All patients were followed for 12 years. Fifteen of the patients had local and distant recurrences. VEGF immunostaining was evaluated semiquantitatively by a pathologist. The difference between the recurrent (n = 15) and nonrecurrent (n = 30) carcinomas was statistically significant (P = 0.001). VEGF expression was also stronger in papillary thyroid carcinomas than in normal thyroid tissues (P = 0.001). There was a statistically significant correlation among the tumor size, regional recurrence, distant metastasis, and the VEGF expression. These data indicate that VEGF staining is strongly associated with an increased frequency of recurrence in papillary thyroid cancer and that the immunohistochemical profile of the expression may be used as a marker for predicting which tumors have metastatic potential
Primary hydatid disease in the adrenal gland: a case report
Hydatid cysts may be found in almost any part of the body, but most often they are found in the liver and lungs. Other organs that are occasionally affected include the brain, muscle, kidney, heart, pancreas, and adrenal and thyroid glands. We report a case of hydatid cyst of the adrenal gland
Clinical and radiological features of adrenal cysts
Adrenal cysts are very rare lesions, usually asymptomatic or without characteristic symptoms. They are classified as pseudocysts, endothelial cysts, epithelial cysts or parasitic cysts. Although pseudocysts are reported to be the most common clinically recognized adrenal cysts in surgical series, endothelial cysts are more common in autopsy series. We studied 15 consecutive patients with adrenal cysts who underwent surgical resection at our institution from 1990 to 2005. Of 15 patients with adrenal cysts, 10 had pseudocysts, 3 epithelial cysts, 1 an endothelial cyst and 1 a parasitic cyst. In conclusion, a better understanding of cystic adrenal masses is necessary to recognize true adrenal cysts and differentiating them from adrenal carcinoma or adenoma by demonstrating the foci of cystic or degenerative changes. Copyright (c) 2008 S. Karger AG, Basel